ARCHIVES

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 24 | June 15, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012

Cooperative Group Problems, Solutions Analyzed By CTEP Staff

May 2, 1986

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

June 15, 2007

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

In Brief: Little Relation of Cancer Incidence To Known Carcinogens Except For Cigarettes, Holleb Says

July 14, 1978